Abstracts

SARS-CoV-2 SURVEILLANCE IN 14 HEALTH FACILITIES IN MALAWI

As of October 26, 2020, Malawi reported 5,894 confirmed COVID-19 cases with 183 deaths. A state of disaster was declared in March; however, a strict lockdown order was never issued. Malawi has implemented a testing strategy involving screening and testing only symptomatic persons due to limited availability of tests. Sentinel surveillance was conducted with the…

CUMULATIVE INCIDENCE OF SARS-CoV-2 INFECTION AND EPIDEMIC METRICS, UNITED STATES

Understanding the cumulative incidence of SARS-CoV-2 infections in the United States has been limited by asymptomatic infections, waning antibodies after natural infection, incomplete case ascertainment and reporting, and limited representative samples. We conducted a probability survey of US households to measure SARS-CoV-2 infection and immune response and to estimate the cumulative incidence of SARS-CoV-2 infection.…

RECENT SARS-CoV-2 SEROCONVERSION IN A NATIONAL PROSPECTIVE COHORT OF US ADULTS

Epidemiologic risk factors for SARS-CoV-2 infection are best characterized via prospective cohort studies, complementing case-based surveillance and cross-sectional seroprevalence studies. We estimated the cumulative incidence of SARS-CoV-2 infection and incidence rates of seroconversion in a national prospective online cohort of 6745 US adults, enrolled during March-July 2020. A subset (n=4459) underwent serologic testing (Bio-Rad Platelia…

US POPULATION-BASED SURVEY OF VACCINE WILLINGNESS AND SARS-CoV-2 ANTIBODY PREVALENCE

Developing representative estimates of COVID-19 vaccine acceptance will be essential to public health planning as the vaccine supply moves towards sufficiency in meeting initial levels of demand. We conducted a national probability household survey to assess vaccine willingness and history of SARS-CoV-2 infection based on antibody response. Study materials were sent to an address-based sample…

PREVALENCE OF ANTI–SARS-CoV-2 ANTIBODIES IN SOUTH AFRICAN BLOOD DONORS

Given the inevitable, likely substantial, under-ascertainment of SARS-CoV-2 infection at the population level, using routine laboratory testing, the prevalence of SARS-CoV-2 antibodies (‘seroprevalence’) is an important marker of Covid-19 epidemiology. As nationally representative household surveys are a major undertaking, it will be important to find efficient ways to reliably estimate antibody prevalence from much simpler,…

DETERMINANTS OF COVID-19 HOSPITAL OUTCOMES IN A LARGE PENNSYLVANIA HEALTH SYSTEM

Individuals hospitalized with COVID-19 exhibit a wide spectrum of disease. There is growing evidence that racial and ethnic minorities bear a disproportionate burden from COVID-19. Temporal changes in the pandemic epidemiology require careful study to identify determinants of poor outcomes. We assessed patient socio-demographics, comorbidities, baseline severity, treating hospital and pandemic month as independent risk…

HIV VIRAL LOAD PATTERNS WITHIN 2 YEARS AFTER DIAGNOSIS IN WASHINGTON, DC

Sustained viral suppression (VS) following early treatment initiation among people diagnosed with HIV is key to reducing mortality, opportunistic infections, and transmission. We examined viral load (VL) patterns and associated demographics 2 years after diagnosis for the District of Columbia (DC). Using DC’s surveillance data, we included people diagnosed with HIV in 2016-2017 residing in…